FEDERAL STRATEGY CONSULTING for WELLDOC COMMUNICATIONS INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
H.R. 962 / S. 452 - Medicare Diabetes Prevention Act of 2013 H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act H.R. 1257 - Preventing Diabetes in Medicare Act H.R. 1274 / S. 945 - Access to Quality Diabetes Education Act of 2013 S. 557 - Medication Therapy Management Empowerment Act H.R. 3322 - Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013 H.R. 2845 / S. 1935 - Diabetic Testing Supply Access of 2013/14 H.R. 3591 - Minority Diabetes Initiative Act H.R. 2415 / S. 1184 - Treat and Reduce Obesity Act of 2013 S. 596 - Fostering Independence Through Technology Act of 2013 H.R. 2524 / S. 1228 - Medicare Better Health Rewards Program Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE P PAWELCZYK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.